$TMTC
TMT Acquisition Corp Stock $tmtc

$tmtc Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000149315224014373 Filed on April 12, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$290.5K	$340.6K	$690.6K
YoY Change	123.43%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$290.5K	$340.6K	$690.6K
YoY Change	123.43%	189127.78%	130203.77%
Operating Profit	-$290.5K		-$690.6K
YoY Change	117.05%		131195.25%
Interest Expense	$597.7K	$853.5K	$2.260M
YoY Change	-0.38%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$307.2K	$512.9K	$1.570M
YoY Change	-34.63%	-285055.56%	-296301.89%
Income Tax
% Of Pretax Income
Net Earnings	$307.2K	$512.9K	$1.570M
YoY Change	-34.45%	-285055.56%	-296300.94%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	$0.04	$0.06	$0.19
COMMON SHARES
Basic Shares Outstanding	8.140M shares	8.140M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q2	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$680.00	$46.78K	$46.78K
YoY Change	-99.43%	-1.47%	-1.47%
Cash & Equivalents	$0.00	$0.00
Short-Term Investments
Other Short-Term Assets	$82.41K	$59.53K	$59.53K
YoY Change	-25.08%	752.87%	752.87%
Inventory
Prepaid Expenses	$82.41K	$59.53K
Receivables
Other Receivables
Total Short-Term Assets	$83.09K	$106.3K	$106.3K
YoY Change	-68.6%	95.21%	95.21%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$65.46M	$63.46M	$63.46M
YoY Change	5.92%
Other Assets		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Total Long-Term Assets	$65.46M	$63.46M	$63.46M
YoY Change	5.86%	14216.12%	14216.12%
TOTAL ASSETS
Total Short-Term Assets	$83.09K	$106.3K	$106.3K
Total Long-Term Assets	$65.46M	$63.46M	$63.46M
Total Assets	$65.54M	$63.57M	$63.57M
YoY Change	5.55%	12671.08%	12671.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$679.0K	$399.0K	$399.0K
YoY Change	440.58%	933.2%	933.2%
Deferred Revenue
YoY Change
Short-Term Debt	$800.0K	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.623M	$409.0K	$409.0K
YoY Change	1097.07%	-15.25%	-15.25%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.623M	$409.0K	$409.0K
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$1.623M	$409.0K	$409.0K
YoY Change	1097.07%	-15.25%	-15.25%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.540M	-$302.9K
YoY Change	539.4%	2960.78%
Common Stock	$214.00	$214.00
YoY Change	0.0%	23.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.540M	-$302.7K	$63.16M
YoY Change
Total Liabilities & Shareholders Equity	$65.54M	$63.57M	$63.57M
YoY Change	5.55%	12671.08%	12671.08%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$307.2K	$512.9K	$1.570M
YoY Change	-34.45%	-285055.56%	-296300.94%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$770.00	-$50.20K	-$372.8K
YoY Change	-100.37%	1180.61%	2632.88%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$600.0K	$0.00	-$61.20M
YoY Change
Cash From Investing Activities	-$600.0K	$0.00	-$61.20M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	300.0K	34.32K	$61.57M
YoY Change		-1409.92%	-44434.72%
NET CHANGE
Cash From Operating Activities	770.0	-50.20K	-$372.8K
Cash From Investing Activities	-600.0K	0.000	-$61.20M
Cash From Financing Activities	300.0K	34.32K	$61.57M
Net Change In Cash	-299.2K	-15.88K	-$700.00
YoY Change	42.49%	142.81%	-99.54%
FREE CASH FLOW
Cash From Operating Activities	$770.00	-$50.20K	-$372.8K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023Q4	us-gaap	Deferred Costs DeferredCosts		usd
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Temporary Equity Value Excluding Additional Paid In Capital TemporaryEquityValueExcludingAdditionalPaidInCapital		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2022	us-gaap	Administrative Fees Expense AdministrativeFeesExpense		usd
CY2022	TMTCU	Income From Investments Held In Trust Account IncomeFromInvestmentsHeldInTrustAccount		usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited		usd
CY2022	TMTCU	Income From Investments Held In Trust Account IncomeFromInvestmentsHeldInTrustAccount		usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties		usd
CY2022	TMTCU	Investment Of Cash Into Trust Account InvestmentOfCashIntoTrustAccount		usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
CY2022	TMTCU	Payment Of Underwriting Discount PaymentOfUnderwritingDiscount		usd
CY2023	TMTCU	Deferred Offering Costs Included In Accrued Expenses DeferredOfferingCostsIncludedInAccruedExpenses		usd
CY2023	TMTCU	Reclassification Of Amount Due To Related Party To Promissory Note ReclassificationOfAmountDueToRelatedPartyToPromissoryNote		usd
CY2022	TMTCU	Deferred Offering Costs Charged To Apic DeferredOfferingCostsChargedToAPIC		usd
CY2022	TMTCU	Note Payable To Related Party Converted To Subscription Of Private Placement NotePayableToRelatedPartyConvertedToSubscriptionOfPrivatePlacement		usd
CY2022	TMTCU	Allocation Of Offering Costs To Ordinary Shares Subject To Redemption AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption		usd
CY2022	TMTCU	Reclassification Of Ordinary Shares Subject To Redemption ReclassificationOfOrdinarySharesSubjectToRedemption		usd
CY2022	TMTCU	Remeasurement Adjustment On Ordinary Shares Subject To Possible Redemption RemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption		usd
CY2022	TMTCU	Issuance Of Representative Shares At Fair Value IssuanceOfRepresentativeSharesAtFairValue		usd
CY2022	TMTCU	Forfeiture Of Ordinary Shares ForfeitureOfOrdinaryShares		usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments		usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-41667
CY2023	dei	Entity Registrant Name EntityRegistrantName	TMT Acquisition Corp
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	420 Lexington Avenue
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 2446
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10170
CY2023	dei	City Area Code CityAreaCode	(347)
CY2023	dei	Local Phone Number LocalPhoneNumber	627-0058
CY2023	dei	Security12g Title Security12gTitle	None
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	true
CY2023Q2	dei	Entity Public Float EntityPublicFloat	65643060	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	8140000	shares
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	1195
CY2023	dei	Auditor Name AuditorName	UHY LLP
CY2023	dei	Auditor Location AuditorLocation	New York, New York
CY2023Q4	us-gaap	Cash Cash	46778	usd
CY2022Q4	us-gaap	Cash Cash	47478	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	59531	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	6979	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	106309	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	54457	usd
CY2022Q4	us-gaap	Deferred Costs DeferredCosts	443284	usd
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	63460478	usd
CY2023Q4	us-gaap	Assets Assets	63566787	usd
CY2022Q4	us-gaap	Assets Assets	497741	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	399020	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	38620	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	409020	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	482638	usd
CY2023Q4	us-gaap	Liabilities Liabilities	409020	usd
CY2022Q4	us-gaap	Liabilities Liabilities	482638	usd
CY2023Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	6000000	shares
CY2022Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	6000000	shares
CY2023Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	10.58
CY2022Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	10.58
CY2023Q4	us-gaap	Temporary Equity Value Excluding Additional Paid In Capital TemporaryEquityValueExcludingAdditionalPaidInCapital	63460478	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2140000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2140000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1725000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1725000	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	214	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	173	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24827	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-302925	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9897	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-302711	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15103	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	63566787	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	497741	usd
CY2023	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	100000	usd
CY2023	us-gaap	Direct Operating Costs DirectOperatingCosts	590613	usd
CY2022	us-gaap	Direct Operating Costs DirectOperatingCosts	526	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-690613	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-526	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	15629	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-526	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15103	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15103	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	60000000	usd
CY2023	TMTCU	Stock Issued During Period Value Proceeds From Sale Of Private Placement Units StockIssuedDuringPeriodValueProceedsFromSaleOfPrivatePlacementUnits	3700000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-1200000	usd
CY2023	TMTCU	Stock Issued During Period Value Representative Shares Issued StockIssuedDuringPeriodValueRepresentativeSharesIssued	1741500	usd
CY2023	TMTCU	Adjustments To Additional Paid In Capital Other Offering Costs AdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts	-2668701	usd
CY2023	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	-58645200	usd
CY2023	TMTCU	Adjustments To Additional Paid In Capital Allocation Of Offering Costs To Ordinary Shares Subject To Redemption AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption	3781346	usd
CY2023	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	-6336146	usd
CY2023	TMTCU	Subsequent Measurement Of Ordinary Shares Subject To Possible Redemption SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption	-2260478	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-302711	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-302711	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	1569865	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-526	usd
CY2023	TMTCU	Income From Investments Held In Trust Account IncomeFromInvestmentsHeldInTrustAccount	2260478	usd
CY2023	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	10000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	52552	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	6979	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	360400	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-6138	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-372765	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13643	usd
CY2023	TMTCU	Investment Of Cash Into Trust Account InvestmentOfCashIntoTrustAccount	61200000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-61200000	usd
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	60000000	usd
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	3255982	usd
CY2023	TMTCU	Payment Of Underwriting Discount PaymentOfUnderwritingDiscount	1200000	usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	483917	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	138879	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	61572065	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-700	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	47478	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	46778	usd
CY2022	TMTCU	Deferred Offering Costs Included In Accrued Expenses DeferredOfferingCostsIncludedInAccruedExpenses	4073	usd
CY2022	TMTCU	Reclassification Of Amount Due To Related Party To Promissory Note ReclassificationOfAmountDueToRelatedPartyToPromissoryNote	244018	usd
CY2023	TMTCU	Deferred Offering Costs Charged To Apic DeferredOfferingCostsChargedToAPIC	2668701	usd
CY2023	TMTCU	Note Payable To Related Party Converted To Subscription Of Private Placement NotePayableToRelatedPartyConvertedToSubscriptionOfPrivatePlacement	444018	usd
CY2023	TMTCU	Allocation Of Offering Costs To Ordinary Shares Subject To Redemption AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption	3781346	usd
CY2023	TMTCU	Reclassification Of Ordinary Shares Subject To Redemption ReclassificationOfOrdinarySharesSubjectToRedemption	58645200	usd
CY2023	TMTCU	Remeasurement Adjustment On Ordinary Shares Subject To Possible Redemption RemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption	8596624	usd
CY2023	TMTCU	Issuance Of Representative Shares At Fair Value IssuanceOfRepresentativeSharesAtFairValue	1741500	usd
CY2023	TMTCU	Forfeiture Of Ordinary Shares ForfeitureOfOrdinaryShares	23	usd
CY2023	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2021-07-06
CY2023Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10.20
CY2023Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10.20
CY2023Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10.20
CY2023	TMTCU	Cash Deposited Into Trust Account CashDepositedIntoTrustAccount	61200000	usd
CY2023Q4	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	3868701	usd
CY2023	us-gaap	Payments For Underwriting Expense PaymentsForUnderwritingExpense	1200000	usd
CY2023Q4	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	2668701	usd
CY2023Q4	us-gaap	Cash Cash	46778	usd
CY2023Q4	TMTCU	Working Capital WorkingCapital	302711	usd
CY2023Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	600000	usd
CY2023Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.10
CY2023	us-gaap	Interest Expense Deposits InterestExpenseDeposits	1800000	usd
CY2023Q4	us-gaap	Share Price SharePrice	0.30
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_849_eus-gaap--UseOfEstimates_zAoViGF8YVL7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zxgZ5PGNwFlf">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_zobRfEqSYF42" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_zR1hKhEyenx6">Concentration of Credit Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $<span id="xdx_90C_eus-gaap--CashFDICInsuredAmount_iI_c20231231_zOljf9Xn6Gki" title="Cash FDIC insured amount">250,000</span>. As on December 31, 2023, and December 31, 2022, the Company did not experience losses on this account and management believes the Company is not exposed to significant risks on such account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	1569865	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-526	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-2260478	usd
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	6336146	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7026759	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-526	usd
CY2023Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.58
CY2022Q1	TMTCU	Business Acquisitions Name Of Acquired Entity BusinessAcquisitionsNameOfAcquiredEntity	The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of their founder shares until the earlier of: (A) one year after the completion of the initial Business Combination or (B) subsequent to our Business Combination, the last sale price of the ordinary share (x) equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination, or (y) the date following the completion of the initial Business Combination on which the Company completes a liquidation, merger, stock exchange or other similar transaction that results in all of the public shareholders having the right to exchange their ordinary shares for cash, securities or other property.
CY2023	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	100000	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023	us-gaap	Common Stock Voting Rights CommonStockVotingRights	Holders of Class A and Class B ordinary shares were entitled to one vote for each share.
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2140000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2140000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1725000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1725000	shares
CY2023	us-gaap	Sale Of Stock Description Of Transaction SaleOfStockDescriptionOfTransaction	Simultaneously with the closing of the IPO, the Company issued to Maxim Partners LLC, pursuant to the underwriting agreement, 270,000 Representative Shares (the “Representative Shares”). The underwriter has agreed not to transfer, assign or sell any such Representative Shares without prior consent of the Company until the completion of the initial Business Combination.
CY2023	TMTCU	Fair Value Of Representative Shares FairValueOfRepresentativeShares	1741500	usd
CY2022Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	0	usd
CY2023Q1	us-gaap	Share Price SharePrice	6.45

Files In Submission

Name	View Source	Status
0001493152-24-014373-index-headers.html	Edgar Link	pending
0001493152-24-014373-index.html	Edgar Link	pending
0001493152-24-014373.txt	Edgar Link	pending
0001493152-24-014373-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
ex97-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tmtcu-20231231.xsd	Edgar Link	pending
tmtcu-20231231_def.xml	Edgar Link	unprocessable
tmtcu-20231231_pre.xml	Edgar Link	unprocessable
tmtcu-20231231_lab.xml	Edgar Link	unprocessable
tmtcu-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TMTC
TMT Acquisition Corp Stock $tmtc

2024 Q2 Form 10-K Financial Statement

#000149315224014373 Filed on April 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TMTC TMT Acquisition Corp Stock $tmtc

2024 Q2 Form 10-K Financial Statement

#000149315224014373 Filed on April 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TMTC
TMT Acquisition Corp Stock $tmtc